These results all suggested that in addition to intratumoral production via aromatase pathway, 17βHSD1 is active and contributes to tumor progression of estrogen dependent NSCLC cells by making use of available intratumoral E1. The gene discussed is CYP19A1; the disease is non-small cell lung carcinoma.